Who are Thioctic acid's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Pycnogenol®, Cilostazol+Probucol, Coenzyme Q10 (drug), Vitamin E ointment application, Q10 Coenzyme, Vitamin C & Vitamin E.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/thioctic-acid.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

Thioctic acid — Competitive Intelligence Brief

Thioctic acid (Thioctic acid) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antioxidant; mitochondrial cofactor. Area: Neurology; Endocrinology; Metabolic disorders.

marketed Antioxidant; mitochondrial cofactor Neurology; Endocrinology; Metabolic disorders Small molecule Live · refreshed every 30 min

Target snapshot

Thioctic acid (Thioctic acid) — The Dana Foundation. Thioctic acid (alpha-lipoic acid) is an antioxidant that regenerates other antioxidants and improves mitochondrial energy metabolism.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Thioctic acid TARGET	Thioctic acid	The Dana Foundation	marketed	Antioxidant; mitochondrial cofactor
Pycnogenol®	Pycnogenol®	University of Zurich	marketed	Botanical extract / Antioxidant
Cilostazol+Probucol	Cilostazol+Probucol	Otsuka Beijing Research Institute	marketed	Antiplatelet agent + Antioxidant lipid-lowering agent	Phosphodiesterase-3 (cilostazol); Antioxidant mechanism (probucol)
Coenzyme Q10 (drug)	Coenzyme Q10 (drug)	University of Shizuoka	marketed	Mitochondrial cofactor / Antioxidant	Mitochondrial electron transport chain (Complexes I-III, Complex IV)
Vitamin E ointment application	Vitamin E ointment application	Hospital General Universitario Elche	marketed	Topical antioxidant
Q10 Coenzyme	Q10 Coenzyme	Central Hospital, Nancy, France	marketed	Mitochondrial cofactor / Antioxidant	Mitochondrial electron transport chain (Complexes I, II, III)
Vitamin C & Vitamin E	Vitamin C & Vitamin E	Shiraz University of Medical Sciences	marketed	Antioxidant vitamin combination

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antioxidant; mitochondrial cofactor class)

The Catholic University of Korea · 1 drug in this class
The Dana Foundation · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Thioctic acid — Competitive Intelligence Brief. https://druglandscape.com/ci/thioctic-acid. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab